Similar articles

• [Decrease in auricular fibrillations by use of disopyramide. 70 trials].

  Rullière R, Vial F, Pornin M. Rullière R, et al. Nouv Presse Med. 1976 Feb 28;5(9):581-2. Nouv Presse Med. 1976. PMID: 772612 Clinical Trial. French. No abstract available.
• [Oral longterm therapy with disopyramide phosphate in patients with atrial and ventricular arrhythmias (author's transl)].

  Stauch M, Grewe N. Stauch M, et al. MMW Munch Med Wochenschr. 1977 Dec 2;119(48):1563-6. MMW Munch Med Wochenschr. 1977. PMID: 74799 German.
• Clinical studies of Norpace (Part IV).

  Jutzy RV. Jutzy RV. Angiology. 1975 Jan;26(1 Pt 2):138-9. Angiology. 1975. PMID: 803798 Clinical Trial. No abstract available.
• [Clinical pharmacology of disopyramide].

  Rewerski W, Dorociak A, Walczak F, Dobiasz A. Rewerski W, et al. Pol Tyg Lek. 1980 Jul 21;35(29):1109-12. Pol Tyg Lek. 1980. PMID: 7001399 Review. Polish. No abstract available.
• Clinical pharmacokinetics of disopyramide.

  Karim A, Nissen C, Azarnoff DL. Karim A, et al. J Pharmacokinet Biopharm. 1982 Oct;10(5):465-94. doi: 10.1007/BF01059032. J Pharmacokinet Biopharm. 1982. PMID: 6762414 Review. No abstract available.